» Articles » PMID: 16132279

Evaluation of Preclinical Atherosclerosis by Flow-mediated Dilatation of the Brachial Artery and Carotid Artery Analysis in Patients with a History of Kawasaki Disease

Overview
Journal Pediatr Cardiol
Date 2005 Sep 1
PMID 16132279
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiac sequelae of Kawasaki disease are an important cause of ischemic heart disease in young adults. The possibility of early progression of atherosclerosis following Kawasaki disease is therefore of great concern. We examined whether preclinical atherosclerotic changes are seen in patients with a history of Kawasaki disease, and whether these changes appear in all or in only a proportion of patients. Sixty-five patients with a history of Kawasaki disease, aged 13.1 +/- 2.1 years, and 20 aged-matched controls participated in the study. All subjects underwent flow-mediated dilatation (FMD) of the brachial artery and analysis of carotid artery size and pulse-wave transmission. Patients were classified into four groups depending on the severity of the maximum coronary artery lesion: group 0 (normal), group 1 (mild), group 2 (moderate), and group 3 (severe). There was no statistical difference in the carotid artery analyses between the four groups. FMD (mean +/- SD) was significantly lower in groups 2 and 3 than in groups 0 and 1 and the control group (group 0, 19.4 +/- 3.9%; group 1, 19.5 +/-4.1%; group 2, 8.9 +/- 2.8%; group 3, 4.2 +/- 1.5%; control group, 18.8 +/- 2.8%; p < 0.0001). There was a significantly negative correlation between the severity of the coronary artery lesion and FMD (p < 0.0001 for both). Endothelial dysfunction was revealed by FMD in patients with persistent coronary artery lesions subsequent to Kawasaki disease. Preclinical atherosclerosis may be present only in patients with coronary aneurysms.

Citing Articles

Markers of Endothelial Dysfunction in Kawasaki Disease: An Update.

Kumrah R, Goyal T, Rawat A, Singh S Clin Rev Allergy Immunol. 2024; 66(1):99-111.

PMID: 38462555 DOI: 10.1007/s12016-024-08985-5.


Roles of Oxidative Injury and Nitric Oxide System Derangements in Kawasaki Disease Pathogenesis: A Systematic Review.

Tsuge M, Uda K, Eitoku T, Matsumoto N, Yorifuji T, Tsukahara H Int J Mol Sci. 2023; 24(20).

PMID: 37895129 PMC: 10607378. DOI: 10.3390/ijms242015450.


Kawasaki Disease: Pathology, Risks, and Management.

Seki M, Minami T Vasc Health Risk Manag. 2022; 18:407-416.

PMID: 35711626 PMC: 9196282. DOI: 10.2147/VHRM.S291762.


Cardiovascular risk in children: a burden for future generations.

Candelino M, Tagi V, Chiarelli F Ital J Pediatr. 2022; 48(1):57.

PMID: 35410281 PMC: 8996670. DOI: 10.1186/s13052-022-01250-5.


Assessment of vascular and endothelial function in Kawasaki disease.

Lo M, Lin Y, Kuo H, Wu Y, Li T, Kuo H Biomed J. 2022; 46(2):100525.

PMID: 35358713 PMC: 10267959. DOI: 10.1016/j.bj.2022.03.010.


References
1.
Celermajer D, Sorensen K, Gooch V, Spiegelhalter D, Miller O, Sullivan I . Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992; 340(8828):1111-5. DOI: 10.1016/0140-6736(92)93147-f. View

2.
Neunteufl T, Katzenschlager R, Hassan A, Klaar U, Schwarzacher S, Glogar D . Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis. 1997; 129(1):111-8. DOI: 10.1016/s0021-9150(96)06018-2. View

3.
Suzuki A, Kamiya T, Arakaki Y, Kinoshita Y, Kimura K . Fate of coronary arterial aneurysms in Kawasaki disease. Am J Cardiol. 1994; 74(8):822-4. DOI: 10.1016/0002-9149(94)90446-4. View

4.
Urabe T . Differentiation of embolic and thrombotic middle cerebral artery occlusion using ultrasonic carotid flow velocity analysis. J Neurol Sci. 1995; 128(2):181-7. DOI: 10.1016/0022-510x(94)00213-8. View

5.
Schroeder S, Enderle M, Ossen R, Meisner C, Baumbach A, Pfohl M . Noninvasive determination of endothelium-mediated vasodilation as a screening test for coronary artery disease: pilot study to assess the predictive value in comparison with angina pectoris, exercise electrocardiography, and myocardial perfusion.... Am Heart J. 1999; 138(4 Pt 1):731-9. DOI: 10.1016/s0002-8703(99)70189-4. View